Mohtashim Lohani Selected Research

Diabetes Complications

1/2018

Inhibition of C298S mutant of human aldose reductase for antidiabetic applications: Evidence from in silico elementary mode analysis of biological network model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohtashim Lohani Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 01/2012
7	Infections 01/2021 - 11/2016
4	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2016
4	Pulmonary Tuberculosis 01/2021 - 06/2017
3	Carcinogenesis 01/2019 - 01/2014
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2019 - 01/2004
3	Lung Neoplasms (Lung Cancer) 01/2017 - 01/2011
2	Carcinoma (Carcinomatosis) 07/2019 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 08/2016
2	Communicable Diseases (Infectious Diseases) 09/2018 - 01/2017
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2018 - 01/2018
2	Melanoma (Melanoma, Malignant) 05/2018 - 03/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Necrosis 07/2019
1	HIV Infections (HIV Infection) 09/2018
1	Systemic Scleroderma (Systemic Sclerosis) 07/2018
1	Autoimmune Diseases (Autoimmune Disease) 07/2018
1	Diabetes Complications 01/2018
1	Tuberculosis (Tuberculoses) 01/2018
1	Cataract (Cataracts) 01/2018
1	Leprosy (Hansen's Disease) 10/2017
1	Rheumatoid Arthritis 05/2017
1	Skin Neoplasms (Skin Cancer) 03/2017
1	Jaundice (Icterus) 01/2017
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2017
1	Cholecystitis 01/2017
1	Dengue (Dengue Fever) 01/2017
1	Diarrhea 01/2017
1	Disease Progression 08/2016
1	Alzheimer Disease (Alzheimer's Disease) 01/2015
1	Huntington Disease (Huntington's Disease) 01/2015
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2015

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2014
6	Pharmaceutical PreparationsIBA 01/2022 - 01/2015
4	EnzymesIBA 01/2018 - 01/2012
3	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2019 - 06/2017
3	Biological ProductsIBA 01/2019 - 10/2015
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 12/2018
2	Peptides (Polypeptides)IBA 01/2022 - 01/2018
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021 - 01/2018
2	Cell-Free Nucleic AcidsIBA 07/2019 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 07/2019 - 01/2017
2	SurvivinIBA 01/2019 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 10/2017
2	LectinsIBA 01/2019 - 09/2018
2	VaccinesIBA 09/2018 - 01/2017
2	EpitopesIBA 09/2018 - 01/2017
2	Monoclonal AntibodiesIBA 03/2017 - 08/2016
2	Glutathione (Reduced Glutathione)IBA 01/2017 - 01/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 10/2015
2	titanium dioxide (Titania)FDA Link 01/2011 - 08/2002
1	ChitosanIBA 01/2022
1	Human Growth Hormone (Saizen)FDA LinkGeneric 01/2022
1	Drug CarriersIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	InterferonsIBA 05/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2019
1	CarcinogensIBA 01/2019
1	NAD (NADH)IBA 01/2019
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2019
1	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 01/2019
1	Apoptosis Regulatory ProteinsIBA 12/2018
1	Arginine (L-Arginine)FDA Link 08/2018
1	CytokinesIBA 07/2018
1	Caveolin 1IBA 05/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Sorbitol (Yal)FDA Link 01/2018
1	Aldehyde Reductase (Aldose Reductase)IBA 01/2018
1	Oxidoreductases (Dehydrogenase)IBA 01/2018
1	Carboxy-LyasesIBA 01/2018
1	Dihydrodipicolinate ReductaseIBA 01/2018
1	NADP (NADPH)IBA 01/2018
1	Aspartic Acid (Aspartate)FDA Link 01/2018
1	Interleukin-10 (Interleukin 10)IBA 10/2017
1	methyl 4-azidophenylacetimidate (APAI)IBA 09/2017
1	Interleukin-6 (Interleukin 6)IBA 05/2017
1	IpilimumabIBA 03/2017
1	pembrolizumabIBA 03/2017
1	Parathion (Ethyl Parathion)IBA 01/2017
1	RotenoneIBA 01/2017
1	CatalaseIBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	Lipid PeroxidesIBA 01/2017
1	Genetic Markers (Genetic Marker)IBA 11/2016
1	Trastuzumab (Herceptin)FDA Link 08/2016
1	Bevacizumab (Avastin)FDA Link 08/2016
1	chryseneIBA 07/2016
1	Matrix Metalloproteinases (MMPs)IBA 10/2015
1	EndopeptidasesIBA 01/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2015
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2015
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2015

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2022
1	Radiotherapy 12/2018
1	Therapeutics 03/2017